mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.6 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |